FDA GRANTS PRIORITY REVIEW FOR GENENTECH’S CANCER IMMUNOTHERAPY ATEZOLIZUMAB IN SPECIFIC TYPE OF LUNG CANCER SOUTH SAN FRANCISCO, Calif. – April 10, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Alecensa® (alectinib) for the treatment of people with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have
Doctor at Baptist Medical Center in Winston-Salem are making some exciting discoveries about lung cancer. WXII 12's Kimberly Van Scoy explains.
Lung cancer is the No. 1 killer of men and women. But you can survive it by doing very very important thing. WXII 12's Kimberly Van Scoy explains.
A new study talks of the importance of detecting early signs of lung cancer; Kimberly Van Scoy reports.
Six carbonyl compounds in exhaled breath effectively discriminate between lung cancer patients and healthy controls as well as in those with benign pulmonary nodules, according to a new study. This could be used to easily detect the presence of malignancy - See more at:
Lung cancer patients live longer if they quit smoking around the time of their cancer diagnosis, a new study finds.
The U.S. Food and Drug Administration approved AstraZeneca Plc's drug, Iressa, as a first-line treatment for untreated non-small-cell lung cancer
In a new study, researchers performed a phase 3 clinical trial to test how combining chemotherapy with immunotherapy improves advanced untreated squamous non-small-cell lung cancer patients’ outcomes.
Researchers at The Valley Hospital and a private lab have developed a blood test that they hope will someday help to detect early-stage lung cancer when it’s most treatable, officials said this week.